ALX Oncology Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
/ 
Frequently asked questions
To buy ALX Oncology Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ALX Oncology Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ALX Oncology Holdings Inc. is ALXO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ALX Oncology Holdings Inc. has its primary listing on NASDAQ. You can trade ALX Oncology Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ALX Oncology Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ALX Oncology Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ALX Oncology Holdings Inc..